☆ 4.7 Meeting Abstract

Updated results for pembrolizumab (pembro) monotherapy as first-line therapy for advanced hepatocellular carcinoma (HCC) in the phase II KEYNOTE-224 study

ANNALS OF ONCOLOGY (2021)

主要评分表示论文的整体质量水平。次要评分独立反映论文的优点或缺点。

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now